Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
The direct delivery of central nervous system (CNS) drugs into the brain after administration is an ideal concept due to its effectiveness and non-toxicity. However, the blood–brain barrier (BBB) prevents drugs from penetrating the capillary endothelial cells, blocking their entry into the brain. Th...
Main Author: | Toshihiko Tashima |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/21/5188 |
Similar Items
-
Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route
by: Ahmad Ainurofiq, et al.
Published: (2023-05-01) -
Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
by: Tyler P. Crowe, et al.
Published: (2022-03-01) -
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
by: Stefaan W. van Gool, et al.
Published: (2013-08-01) -
Clay Nanotubes Loaded with Diazepam or Xylazine Permeate the Brain through Intranasal Administration in Mice
by: Yaswanthi Yanamadala, et al.
Published: (2023-06-01) -
Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease
by: Hala N. ElShagea, et al.
Published: (2023-02-01)